F Tocco1, C M Calò2, M Massidda3,4,5, L Flore2, N Kikuchi6, M Scorcu7,8, F Piras7,8, P Cugia7,8, P Cięszczyk9. 1. Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy. 2. Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy. 3. Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy. myosotis.massidda@unica.it. 4. Italian Federation of Sports Medicine Federation (FMSI), Rome, Italy. myosotis.massidda@unica.it. 5. Faculty of Medicine and Surgery, Sport and Exercise Science Degree Courses, University of Cagliari, Cagliari, Italy. myosotis.massidda@unica.it. 6. Graduate School of Health and Sport Science, Nippon Sport Science University, Tokyo, Japan. 7. Italian Federation of Sports Medicine Federation (FMSI), Rome, Italy. 8. Cagliari Calcio Spa, Cagliari, Italy. 9. Department of Physical Education, University of Physical Education and Sport, Gdańsk, Poland.
Abstract
PURPOSE: The aim of this study is to investigate the influence of the MCT1 T1470A polymorphism (rs1049434) on repeated sprint ability (RSA) and lactate accumulation after RSA testing. METHODS: Twenty-six elite Italian male football players (age: 17.7 ± 0.78 years; height: 179.2 ± 7.40 cm; weight: 72.1 ± 5.38 kg) performed RSA testing (6 × 30-m sprints with an active recovery between sprints), and lactate measurements were obtained at 1, 3, 5, 7, and 10 min post-exercise. Genotyping for the MCT1 T1470A polymorphism was performed using PCR. RESULTS: Genotype distributions were in Hardy-Weinberg equilibrium, being 42% wildtype (A/A), 46% heterozygotes (T/A), and 12% mutated homozygotes (T/T). Significant differences between genotypic groups were found in the two final sprint times of the RSA test. Under a dominant model, carriers of the major A-allele (Glu-490) in the dominant model showed a significantly lower sprint time compared to footballers with the T/T (Asp/Asp) genotype (5th Sprint time: A/A + T/A = 4.60 s vs TT = 4.97 s, 95% CI 0.07-0.67, p = 0.022; 6th Sprint: A/A + T/A = 4.56 s vs T/T = 4.87 s, 95% CI 0.05-0.57, p = 0.033). CONCLUSIONS: The T1470A (Glu490Asp) polymorphism of MCT1 was associated with RSA. Our findings suggest that the presence of the major A-allele (Glu-490) is favourable for RSA in football players.
PURPOSE: The aim of this study is to investigate the influence of the MCT1 T1470A polymorphism (rs1049434) on repeated sprint ability (RSA) and lactate accumulation after RSA testing. METHODS: Twenty-six elite Italian male football players (age: 17.7 ± 0.78 years; height: 179.2 ± 7.40 cm; weight: 72.1 ± 5.38 kg) performed RSA testing (6 × 30-m sprints with an active recovery between sprints), and lactate measurements were obtained at 1, 3, 5, 7, and 10 min post-exercise. Genotyping for the MCT1 T1470A polymorphism was performed using PCR. RESULTS: Genotype distributions were in Hardy-Weinberg equilibrium, being 42% wildtype (A/A), 46% heterozygotes (T/A), and 12% mutated homozygotes (T/T). Significant differences between genotypic groups were found in the two final sprint times of the RSA test. Under a dominant model, carriers of the major A-allele (Glu-490) in the dominant model showed a significantly lower sprint time compared to footballers with the T/T (Asp/Asp) genotype (5th Sprint time: A/A + T/A = 4.60 s vs TT = 4.97 s, 95% CI 0.07-0.67, p = 0.022; 6th Sprint: A/A + T/A = 4.56 s vs T/T = 4.87 s, 95% CI 0.05-0.57, p = 0.033). CONCLUSIONS: The T1470A (Glu490Asp) polymorphism of MCT1 was associated with RSA. Our findings suggest that the presence of the major A-allele (Glu-490) is favourable for RSA in football players.
Authors: A Bonen; D Miskovic; M Tonouchi; K Lemieux; M C Wilson; A Marette; A P Halestrap Journal: Am J Physiol Endocrinol Metab Date: 2000-06 Impact factor: 4.310
Authors: Magdalena Dzitkowska-Zabielska; Aleksandra Bojarczuk; Małgorzata Borczyk; Marcin Piechota; Michał Korostyński; Jakub Grzegorz Adamczyk; Grzegorz Trybek; Myosotis Massidda; Paweł Cięszczyk Journal: Genes (Basel) Date: 2022-05-12 Impact factor: 4.141
Authors: Piotr Łacina; Aleksandra Butrym; Eliza Turlej; Martyna Stachowicz-Suhs; Joanna Wietrzyk; Grzegorz Mazur; Katarzyna Bogunia-Kubik Journal: J Clin Med Date: 2022-01-10 Impact factor: 4.241